267 related articles for article (PubMed ID: 32167970)
1. HIV protease inhibitor ritonavir induces renal fibrosis and dysfunction: role of platelet-derived TGF-β1 and intervention via antioxidant pathways.
Laurence J; Elhadad S; Gostynska S; Yu Z; Terry H; Varshney R; Fung KM; Choi ME; Ahamed J
AIDS; 2020 Jun; 34(7):989-1000. PubMed ID: 32167970
[TBL] [Abstract][Full Text] [Related]
2. HIV protease inhibitor-induced cardiac dysfunction and fibrosis is mediated by platelet-derived TGF-β1 and can be suppressed by exogenous carbon monoxide.
Laurence J; Elhadad S; Robison T; Terry H; Varshney R; Woolington S; Ghafoory S; Choi ME; Ahamed J
PLoS One; 2017; 12(10):e0187185. PubMed ID: 29088262
[TBL] [Abstract][Full Text] [Related]
3. Nordihydroguaiaretic acid (NDGA) inhibits ritonavir-induced endothelial dysfunction in porcine pulmonary arteries.
Lü JM; Nurko J; Jiang J; Weakley SM; Lin PH; Yao Q; Chen C
Med Sci Monit; 2011 Nov; 17(11):BR312-318. PubMed ID: 22037733
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of renal adverse effects of combination anti-retroviral therapy including tenofovir in HIV-infected patients.
Tanaka H; Arai M; Tomoda Y; Wada T; Yago K; Satoh M
J Pharm Pharm Sci; 2013; 16(3):405-13. PubMed ID: 24021289
[TBL] [Abstract][Full Text] [Related]
5. Bardoxolone ameliorates TGF-β1-associated renal fibrosis through Nrf2/Smad7 elevation.
Song MK; Lee JH; Ryoo IG; Lee SH; Ku SK; Kwak MK
Free Radic Biol Med; 2019 Jul; 138():33-42. PubMed ID: 31059771
[TBL] [Abstract][Full Text] [Related]
6. Heme oxygenase-1-derived bilirubin counteracts HIV protease inhibitor-mediated endothelial cell dysfunction.
Liu XM; Durante ZE; Peyton KJ; Durante W
Free Radic Biol Med; 2016 May; 94():218-29. PubMed ID: 26968795
[TBL] [Abstract][Full Text] [Related]
7. Saponins from
Gao Y; Yuan D; Gai L; Wu X; Shi Y; He Y; Liu C; Zhang C; Zhou G; Yuan C
J Ginseng Res; 2021 May; 45(3):408-419. PubMed ID: 34025134
[TBL] [Abstract][Full Text] [Related]
8. Dihydroquercetin protects against renal fibrosis by activating the Nrf2 pathway.
Wang W; Ma BL; Xu CG; Zhou XJ
Phytomedicine; 2020 Apr; 69():153185. PubMed ID: 32120244
[TBL] [Abstract][Full Text] [Related]
9. Lopinavir/ritonavir: a review of its use in the management of HIV infection.
Cvetkovic RS; Goa KL
Drugs; 2003; 63(8):769-802. PubMed ID: 12662125
[TBL] [Abstract][Full Text] [Related]
10. Chalcone flavokawain A attenuates TGF-β1-induced fibrotic pathology via inhibition of ROS/Smad3 signaling pathways and induction of Nrf2/ARE-mediated antioxidant genes in vascular smooth muscle cells.
Hseu YC; Yang TY; Li ML; Rajendran P; Mathew DC; Tsai CH; Lin RW; Lee CC; Yang HL
J Cell Mol Med; 2019 Feb; 23(2):775-788. PubMed ID: 30549180
[TBL] [Abstract][Full Text] [Related]
11. TMC114/ritonavir substitution for protease inhibitor(s) in a non-suppressive antiretroviral regimen: a 14-day proof-of-principle trial.
Arastéh K; Clumeck N; Pozniak A; Lazzarin A; De Meyer S; Muller H; Peeters M; Rinehart A; Lefebvre E;
AIDS; 2005 Jun; 19(9):943-7. PubMed ID: 15905675
[TBL] [Abstract][Full Text] [Related]
12. Role of Platelet-Derived Transforming Growth Factor-β1 and Reactive Oxygen Species in Radiation-Induced Organ Fibrosis.
Ahamed J; Laurence J
Antioxid Redox Signal; 2017 Nov; 27(13):977-988. PubMed ID: 28562065
[TBL] [Abstract][Full Text] [Related]
13. The effect of treatment intensification in HIV-infection: a study comparing treatment with ritonavir/saquinavir and ritonavir/saquinavir/stavudine. Prometheus Study Group.
Gisolf EH; Jurriaans S; Pelgrom J; van Wanzeele F; van der Ende ME; Brinkman K; Borst MJ; de Wolf F; Japour AJ; Danner SA
AIDS; 2000 Mar; 14(4):405-13. PubMed ID: 10770543
[TBL] [Abstract][Full Text] [Related]
14. Biochanin A alleviates unilateral ureteral obstruction-induced renal interstitial fibrosis and inflammation by inhibiting the TGF-β1/Smad2/3 and NF-kB/NLRP3 signaling axis in mice.
Ram C; Gairola S; Syed AM; Kulhari U; Kundu S; Mugale MN; Murty US; Sahu BD
Life Sci; 2022 Jun; 298():120527. PubMed ID: 35378138
[TBL] [Abstract][Full Text] [Related]
15. Integrase inhibitor versus protease inhibitor based regimen for HIV-1 infected women (WAVES): a randomised, controlled, double-blind, phase 3 study.
Squires K; Kityo C; Hodder S; Johnson M; Voronin E; Hagins D; Avihingsanon A; Koenig E; Jiang S; White K; Cheng A; Szwarcberg J; Cao H
Lancet HIV; 2016 Sep; 3(9):e410-e420. PubMed ID: 27562742
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta1 elicits Nrf2-mediated antioxidant responses in aortic smooth muscle cells.
Churchman AT; Anwar AA; Li FYL; Sato H; Ishii T; Mann GE; Siow RCM
J Cell Mol Med; 2009 Aug; 13(8B):2282-2292. PubMed ID: 19674192
[TBL] [Abstract][Full Text] [Related]
17. Continued indinavir versus switching to indinavir/ritonavir in HIV-infected patients with suppressed viral load.
Arnaiz JA; Mallolas J; Podzamczer D; Gerstoft J; Lundgren JD; Cahn P; Fätkenheuer G; D'Arminio-Monforte A; Casiró A; Reiss P; Burger DM; Stek M; Gatell JM;
AIDS; 2003 Apr; 17(6):831-40. PubMed ID: 12660530
[TBL] [Abstract][Full Text] [Related]
18. Asiatic acid inhibits cardiac fibrosis throughNrf2/HO-1 and TGF-β1/Smads signaling pathways in spontaneous hypertension rats.
Meng Z; Li HY; Si CY; Liu YZ; Teng S
Int Immunopharmacol; 2019 Sep; 74():105712. PubMed ID: 31254954
[TBL] [Abstract][Full Text] [Related]
19. Hepatotoxicity associated with protease inhibitor-based antiretroviral regimens with or without concurrent ritonavir.
Sulkowski MS; Mehta SH; Chaisson RE; Thomas DL; Moore RD
AIDS; 2004 Nov; 18(17):2277-84. PubMed ID: 15577540
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid HIV-1 RNA during treatment with ritonavir/saquinavir or ritonavir/saquinavir/stavudine.
Gisolf EH; Enting RH; Jurriaans S; de Wolf F; van der Ende ME; Hoetelmans RM; Portegies P; Danner SA
AIDS; 2000 Jul; 14(11):1583-9. PubMed ID: 10983645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
